Recurrent Adult Diffuse Large Cell Lymphoma
Showing 1 - 25 of 76
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt
Active, not recruiting
- Prolymphocytic Leukemia
- +4 more
- Selinexor
- +3 more
-
Columbus, Ohio
- +1 more
Apr 29, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +99 more
- alemtuzumab
- +6 more
-
Denver, Colorado
- +6 more
Jan 15, 2020
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- chemotherapy
- +6 more
-
Duarte, California
- +4 more
Dec 24, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +99 more
- fludarabine phosphate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 30, 2019
Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic
Completed
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- +115 more
- Fludarabine Phosphate
- +6 more
-
Denver, Colorado
- +10 more
Oct 29, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, CNS Lymphoma, Intraocular
Completed
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
- +5 more
- Dexamethasone
- +3 more
-
Scottsdale, Arizona
- +6 more
Jul 18, 2019
Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial
Completed
- Hematopoietic/Lymphoid Cancer
- +22 more
- CART-19
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
- +33 more
- therapeutic allogeneic lymphocytes
-
Stanford, CaliforniaStanford University
Mar 16, 2019
Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Mantle Cell Lymphoma Trial in ChongQing
Unknown status
- Recurrent Adult Diffuse Large Cell Lymphoma
- +8 more
- CD19.CAR-T cells
-
ChongQing, Chongqing, ChinaDepartment of Oncology
Feb 25, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +110 more
- rituximab
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 6, 2019
Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in
Completed
- Recurrent Adult Diffuse Large Cell Lymphoma
- +7 more
- everolimus
- bendamustine hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis
Jan 2, 2019
Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma Trial in Seattle (drug, biological, other)
Completed
- Recurrent Adult Diffuse Large Cell Lymphoma
- Recurrent Adult Hodgkin Lymphoma
- Bendamustine Hydrochloride
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +117 more
- vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jun 28, 2018
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +26 more
- 6,8-bis(benzylthio)octanoic acid
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018